ArticleActa pharmacologica Sinica2020

Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.

Xiao-Ying Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.